About Genesis AI Corp.: Genesis AI Corp. is committed to developing advanced AI-driven solutions for geospatial analysis, forestry management, and wildfire protection.

Gilead Sciences has struck a deal to work with privately held Genesis Therapeutics to use generative artificial intelligence to discover and develop novel, small-molecule therapies across multiple ...

Genesis Therapeutics’ shiny AI drug discovery platform GEMS is catching on, having now caught the eye of Gilead Sciences. In Genesis' third big pharma collaboration, Gilead has agreed to pay its ...

Gilead Sciences has announced a strategic partnership with Genesis Therapeutics, aimed at using AI to discover and develop new small molecule therapies. The deal will utilise the advanced AI ...

The last of 20 books written by the late Henry Kissinger — this one co-authored by former Google CEO Eric Schmidt and former ...

The collaboration will deploy Genesis' AI platform, GEMS, to assist in generating and optimizing molecules for targets selected by Gilead. Genesis will receive an upfront cash payment of $35 ...

Yes, the massive influx of investments and sky-high evaluations are dropping, but the true AI Revolution is still in its genesis ... but recent earnings from Google and Tesla are not painting ...

Gilead Sciences and artificial intelligence (AI)-focused Genesis Therapeutics have entered into a collaboration aimed at developing small molecule therapies across multiple targets. The partners will ...

Genesis AI Corp. (CSE: AIG) (OTCQB: AIGFF) (the “Company”) is excited to announce the launch of Wildfire Defence Solutions ...